Johnson & Johnson also suggests their branded Concerta products remains obtainable with restrictions to produce, while some generics of extended release methylphenidate hydrochloride are in shortage from these brands:"DEA decided which the proposed APQs for amphetamine, lisdexamfetamine and methylphenidate are sufficient to provide respectable medi